NewsStory
India orders checks on revised prices for 137 cancer medicines
KROV newsroom
DiscussionThe story behind the news.
Opening story…
కథనం తెరుస్తున్నాం…
HomeNews
Opening story…
కథనం తెరుస్తున్నాం…
India’s National Pharmaceutical Pricing Authority has directed state drug controllers to check whether revised retail prices for 137 non-scheduled cancer medicines are reaching patients. The Department of Pharmaceuticals announced the monitoring directive on 13 November and said the revised prices had taken effect on 9 November.
Manufacturers, sellers and hospitals have been told to follow the revised prices and display the latest lists. The authority says the lists are available on its website and on Pharma Sahi Daam. Complaints about overcharging or shortages can be submitted through that service.
State drug controllers have until 16 November to report what action they have taken. The authority says violations can lead to overcharging proceedings.
Cover image is an AI-generated editorial illustration.
More context. A clearer perspective.
Loading comments…
KROV · CONVERSATION
Comments
Share your perspective respectfully. Comments appear after review. Please do not share personal information.